Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.870
-0.270 (-5.25%)
At close: Sep 16, 2025, 4:00 PM EDT
4.900
+0.030 (0.62%)
After-hours: Sep 16, 2025, 7:52 PM EDT
Aquestive Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$10.29
Upside
+111.29%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | +64.27% | Sep 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +105.34% | Jun 17, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $15 → $7 | Buy | Initiates | $15 → $7 | +43.74% | Jun 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +105.34% | May 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +105.34% | Apr 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +105.34% | Mar 10, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +64.27% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +105.34% | Dec 20, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $17 | Buy | Initiates | $17 | +249.08% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +105.34% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +105.34% | Nov 6, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $12 → $13 | Buy | Maintains | $12 → $13 | +166.94% | Oct 25, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +105.34% | Oct 25, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $9 | Buy | Reiterates | $9 | +84.80% | Oct 8, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $9 | Buy | Reiterates | $9 | +84.80% | Sep 30, 2024 |
| Leerink Partners | Leerink Partners | Buy Reiterates $10 → $12 | Buy | Reiterates | $10 → $12 | +146.41% | Sep 30, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.